{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:56:38Z","timestamp":1789602998859,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Natural Science key Project of the Education Department of Anhui Province","award":["2022AH051535"],"award-info":[{"award-number":["2022AH051535"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85241-6","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:27:53Z","timestamp":1736029673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ADAMDEC1 promotes the malignant progression of cholangiocarcinoma by regulating NF-\u03baB signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Shuo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"issue":"6","key":"85241_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/MEG.0000000000002761","volume":"36","author":"NB \u00d6zt\u00fcrk","year":"2024","unstructured":"\u00d6zt\u00fcrk, N. B. & Jamil, L. H. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma. Eur. J. Gastroenterol. Hepatol. 36 (6), 766\u2013774 (2024).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"5","key":"85241_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"Saha, S. K., Zhu, A. X., Fuchs, C. S. & Brooks, G. A. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist 21 (5), 594\u2013599 (2016).","journal-title":"Oncologist"},{"issue":"19","key":"85241_CR3","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.3390\/cancers15194691","volume":"15","author":"D Moris","year":"2023","unstructured":"Moris, D. Surgical management of intrahepatic cholangiocarcinoma: quo vadis. Cancers 15 (19), 4691 (2023).","journal-title":"Cancers"},{"issue":"1","key":"85241_CR4","doi-asserted-by":"publisher","first-page":"2310196","DOI":"10.1080\/07853890.2024.2310196","volume":"56","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Advances in targeted therapy of cholangiocarcinoma. Ann. Med. 56 (1), 2310196 (2024).","journal-title":"Ann. Med."},{"key":"85241_CR5","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","volume":"9","author":"M Qurashi","year":"2023","unstructured":"Qurashi, M., Vithayathil, M. & Khan, S. A. Epidemiology of cholangiocarcinoma. Eur. J. Surg. Oncol. 9, 107064 (2023).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"85241_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00251-002-0430-3","volume":"54","author":"EE Bates","year":"2002","unstructured":"Bates, E. E., Fridman, W. H. & Mueller, C. G. The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12. Immunogenetics 54 (2), 96\u2013105 (2002).","journal-title":"Immunogenetics"},{"issue":"29","key":"85241_CR7","doi-asserted-by":"publisher","first-page":"21367","DOI":"10.1074\/jbc.M113.474536","volume":"288","author":"J Lund","year":"2013","unstructured":"Lund, J. et al. ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity. J. Biol. Chem. 288 (29), 21367\u201321375 (2013).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"85241_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbrc.2019.10.073","volume":"521","author":"T Liu","year":"2020","unstructured":"Liu, T. et al. ADAMDEC1 promotes skin inflammation in rosacea via modulating the polarization of M1 macrophages. Biochem. Biophys. Res. Commun. 521 (1), 64\u201371 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"85241_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/ecco-jcc\/jjw111","volume":"10","author":"NR O\u2019Shea","year":"2016","unstructured":"O\u2019Shea, N. R. et al. Critical role of the disintegrin metalloprotease ADAM-like Decysin-1[ADAMDEC1] for intestinal immunity and inflammation. J. Crohns Colitis. 10 (12), 1417\u20131427 (2016).","journal-title":"J. Crohns Colitis"},{"issue":"5","key":"85241_CR10","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.3390\/ijms24054648","volume":"24","author":"B Lin","year":"2023","unstructured":"Lin, B. et al. The emerging role of MMP12 in the oral environment. Int. J. Mol. Sci. 24 (5), 4648 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"85241_CR11","doi-asserted-by":"publisher","first-page":"16981","DOI":"10.3390\/ijms242316981","volume":"24","author":"S Kuntschar","year":"2023","unstructured":"Kuntschar, S. et al. Mmp12 is translationally regulated in macrophages during the course of inflammation. Int. J. Mol. Sci. 24 (23), 16981 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"85241_CR12","doi-asserted-by":"publisher","first-page":"1093990","DOI":"10.3389\/fimmu.2022.1093990","volume":"13","author":"L He","year":"2023","unstructured":"He, L. et al. The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. Front. Immunol. 13, 1093990 (2023).","journal-title":"Front. Immunol."},{"issue":"17","key":"85241_CR13","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41388-023-02661-2","volume":"42","author":"W Jiang","year":"2023","unstructured":"Jiang, W. et al. KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1\/YBX1 mediated NF-\u03baB pathway in cholangiocarcinoma. Oncogene 42 (17), 1392\u20131404 (2023).","journal-title":"Oncogene"},{"issue":"7","key":"85241_CR14","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1002\/jcp.30759","volume":"237","author":"F Bassiri","year":"2022","unstructured":"Bassiri, F. et al. NF-\u03baB as a regulator of cancer metastasis and therapy response: a focus on epithelial-mesenchymal transition. J. Cell. Physiol. 237 (7), 2770\u20132795 (2022).","journal-title":"J. Cell. Physiol."},{"issue":"15","key":"85241_CR15","doi-asserted-by":"publisher","first-page":"e113126","DOI":"10.15252\/embj.2022113126","volume":"42","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. YTHDF2\/m6 A\/NF-\u03baB axis controls anti-tumor immunity by regulating intratumoral Tregs. EMBO J. 42 (15), e113126 (2023).","journal-title":"EMBO J."},{"issue":"1","key":"85241_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12964-023-01207-z","volume":"21","author":"A Oh","year":"2023","unstructured":"Oh, A. et al. NF-\u03baB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell. Commun. Signal. 21 (1), 291 (2023).","journal-title":"Cell. Commun. Signal."},{"issue":"9","key":"85241_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece, D. et al. NF-\u03baB: blending metabolism, immunity, and inflammation. Trends Immunol. 43 (9), 757\u2013775 (2022).","journal-title":"Trends Immunol."},{"issue":"11","key":"85241_CR18","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1111\/liv.16069","volume":"44","author":"K Xu","year":"2024","unstructured":"Xu, K. et al. Lymphotoxin beta-activated LTBR\/NIK\/RELB axis drives proliferation in cholangiocarcinoma. Liver Int. 44 (11), 2950\u20132963 (2024).","journal-title":"Liver Int."},{"issue":"2","key":"85241_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris, D. et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J. Clin. 73 (2), 198\u2013222 (2023).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"85241_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","volume":"71","author":"P Bertuccio","year":"2019","unstructured":"Bertuccio, P. et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J. Hepatol. 71 (1), 104\u2013114 (2019).","journal-title":"J. Hepatol."},{"issue":"1","key":"85241_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","volume":"19","author":"PL Labib","year":"2019","unstructured":"Labib, P. L., Goodchild, G. & Pereira, S. P. Molecular pathogenesis of cholangiocarcinoma. BMC Cancer. 19 (1), 185 (2019).","journal-title":"BMC Cancer"},{"issue":"7","key":"85241_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1179\/1743132812Y.0000000067","volume":"34","author":"J Xu","year":"2012","unstructured":"Xu, J., Liu, L., Zheng, X., You, C. & Li, Q. Expression and inhibition of ADAMDEC1 in craniopharyngioma cells. Neurol. Res. 34 (7), 701\u2013706 (2012).","journal-title":"Neurol. Res."},{"issue":"9","key":"85241_CR23","first-page":"997","volume":"35","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Knockdown of ADAMDEC1 inhibits the progression of glioma in vitro. Histol. Histopathol. 35 (9), 997\u20131005 (2020).","journal-title":"Histol. Histopathol"},{"issue":"7","key":"85241_CR24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/1759-7714.14354","volume":"13","author":"W Zhu","year":"2022","unstructured":"Zhu, W. et al. Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K\/AKT pathway. Thorac. Cancer. 13 (7), 1027\u20131039 (2022).","journal-title":"Thorac. Cancer"},{"issue":"10","key":"85241_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1164\/rccm.200803-490OC","volume":"179","author":"ED Crouser","year":"2009","unstructured":"Crouser, E. D. et al. Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am. J. Respir Crit. Care Med. 179 (10), 929\u2013938 (2009).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"1","key":"85241_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.21037\/atm-22-6319","volume":"11","author":"N Chai","year":"2023","unstructured":"Chai, N. et al. Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients. Ann. Transl Med. 11 (1), 14 (2023).","journal-title":"Ann. Transl Med."},{"issue":"2","key":"85241_CR27","doi-asserted-by":"publisher","first-page":"113629","DOI":"10.1016\/j.yexcr.2023.113629","volume":"429","author":"Y Jia","year":"2023","unstructured":"Jia, Y. et al. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt\/\u03b2-catenin signaling via negative modulation of GSK-3\u03b2. Exp. Cell. Res. 429 (2), 113629 (2023).","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"85241_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1186\/s12885-021-09065-z","volume":"21","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature. BMC Cancer. 21 (1), 1324 (2021).","journal-title":"BMC Cancer"},{"issue":"7","key":"85241_CR29","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/eji.201948393","volume":"50","author":"M di Lubrano","year":"2020","unstructured":"di Lubrano, M. et al. Tumor necrosis factor receptor family costimulation increases regulatory T-cell activation and function via NF-\u03baB. Eur. J. Immunol. 50 (7), 972\u2013985 (2020).","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"85241_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","volume":"29","author":"DR Edwards","year":"2008","unstructured":"Edwards, D. R., Handsley, M. M. & Pennington C.J. The ADAM metalloproteinases. Mol. Aspects Med. 29 (5), 258\u2013289 (2008).","journal-title":"Mol. Aspects Med."},{"key":"85241_CR31","doi-asserted-by":"publisher","first-page":"e15598","DOI":"10.7717\/peerj.15598","volume":"11","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. MMP12 serves as an immune cell-related marker of disease status and prognosis in lung squamous cell carcinoma. Peer J. 11, e15598 (2023).","journal-title":"Peer J."},{"key":"85241_CR32","doi-asserted-by":"crossref","unstructured":"Zhang, H. et al. KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3\/Akt\/mTOR pathway. Cell. Mol. Life Sci.81(1):96 (2024).","DOI":"10.1007\/s00018-024-05114-5"},{"key":"85241_CR33","doi-asserted-by":"publisher","first-page":"132733","DOI":"10.1016\/j.jhazmat.2023.132733","volume":"461","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Macrophage-derived MMP12 promotes fibrosis through sustained damage to endothelial cells. J. Hazard. Mater. 461, 132733 (2024).","journal-title":"J. Hazard. Mater."},{"issue":"5","key":"85241_CR34","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1021\/acs.jproteome.4c00036","volume":"23","author":"A Zuo","year":"2024","unstructured":"Zuo, A. et al. Integrated exploration of epigenetic dysregulation reveals a stemness\/EMT subtype and MMP12 linked to the progression and prognosis in hepatocellular carcinoma. J. Proteome Res. 23 (5), 1821\u20131833 (2024).","journal-title":"J. Proteome Res."},{"key":"85241_CR35","doi-asserted-by":"crossref","unstructured":"Kerzeli, I. K. et al. Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer. BMC cancer 23(1), 605 (2023).","DOI":"10.1186\/s12885-023-11100-0"},{"issue":"5","key":"85241_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41419-021-03729-1","volume":"12","author":"CL Lin","year":"2021","unstructured":"Lin, C. L. et al. MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1\/MEK3\/p38\/YB1 axis. Cell. Death Dis. 12 (5), 451 (2021).","journal-title":"Cell. Death Dis."},{"key":"85241_CR37","doi-asserted-by":"crossref","unstructured":"Chung, I. C. et al. Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma. BMC cancer 14, 348 (2014).","DOI":"10.1186\/1471-2407-14-348"},{"issue":"3","key":"85241_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10059-013-2269-x","volume":"35","author":"CH Kwon","year":"2013","unstructured":"Kwon, C. H., Moon, H. J., Park, H. J., Choi, J. H. & Park, D. Y. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-\u03baB activation in gastric cancer cells. Mol. Cells. 35 (3), 226\u2013234 (2013).","journal-title":"Mol. Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85241-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T23:11:06Z","timestamp":1736032266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85241"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85241-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"817"}}